- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Novel breath Testing platform Detects Airborne COVID 19 Virus in Exhaled Breath
In a recent study, researchers have unveiled a effective point-of-care testing platform that directly detects SARS-CoV-2 aerosols in exhaled breath of patients, providing results in under 60 seconds. The study was published in the Journal of American Chemical Society.
Airborne transmission via virus-laden aerosols has been identified as a dominant route for the spread of respiratory diseases, including COVID-19. However, screening patients for respiratory virus aerosols has long been a technical challenge. This new platform offers a direct and non-invasive solution to this problem, revolutionizing the field of viral diagnostics.
The platform's core components include a hand-held breath aerosol collector and a llama-derived nanobody, which specifically targets the SARS-CoV-2 spike protein. This nanobody is bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Notably, the electrochemical biosensor directly detects the virus itself, providing a higher level of accuracy compared to surrogate or signature-based testing methods.
Laboratory and clinical trial results have demonstrated that this innovative platform performs with impressive accuracy, producing results within 20% of those obtained using standard testing methods. Even more astonishing is its sensitivity, capable of detecting as few as 10 viral particles in a sample. This remarkable sensitivity ensures early detection, allowing for timely intervention and containment measures.
With results available within a minute, healthcare professionals can rapidly identify and isolate infected individuals, mitigating the risk of virus transmission in hospitals, clinics, and public places. Moreover, the non-invasive nature of the test could encourage more people to get screened, contributing to early detection and containment efforts. As new viruses emerge, this technology can be readily adjusted to target specific pathogens, providing an agile and effective response to emerging threats.
Reference:
Ghumra, D. P., Shetty, N., McBrearty, K. R., Puthussery, J. V., Sumlin, B. J., Gardiner, W. D., Doherty, B. M., Magrecki, J. P., Brody, D. L., Esparza, T. J., Yuede, C. M., Cirrito, J. R., & Chakrabarty, R. K. (2023). Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care. In ACS Sensors. American Chemical Society (ACS). https://doi.org/10.1021/acssensors.3c00512
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751